Report of University Hospital Hradec Králové to the clinical trial protocol No: CSL627_3001

Abstract

Realization of part of clinical trial called: A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII-SingleChain, CSL627) in Subjects With Severe Hemophilia A

Keywords

• Recombinant Coagulation Factor VIII
• Hemophilia A